References
- Lawlor P, Turner K, Hanson J, Bruera ED. Dose ratio between morphine and methadone in patients with cancer pain: a retrospective study. Cancer. 1998;82(6):1167–73.
- Mancini I, Lossignol D, Body JJ. Opioid switch to oral methadone in cancer pain. Curr Opin Oncol. 2000;12(4):308–13.
- Davis M, Walsh D. Methadone for relief of cancer pain: a review of pharmacokinetics, pharmacodynamics, drug interactions and protocols of administration. Support Care Cancer. 2001;9(2):73–83. doi: 10.1007/s005200000180.
- Morley J, Makin M. The use of methadone in cancer pain poorly responsive to other opioids. Pain Rev. 1998;5(1):51–8. doi: 10.1191/096813098673619329.
- Ebert B, Andersen S, Krogsgaard-Larsen P. Ketobemidone, methadone and pethidine are non-competitive N-methyl-D-aspartate (NMDA) antagonists in the rat cortex and spinal cord. Neurosci Lett. 1995;187(3):165–8.
- Weschules DJ, Kevin T, Bain KT. A systematic review of opioid conversion ratios used with methadone for the treatment of pain. Pain Med. 2008; 9(5):595–612. doi: 10.1111/j.1526-4637.2008.00461.x.
- Shaiova L, Berger A, Blinderman CD, Bruera E, Davis MP, Derby S, Inturrisi C, Kalman J, Mehta D, Pappagallo M, et al. Consensus guideline on parenteral methadone use in pain and palliative care. Palliat Support Care. 2008;6(2):165–76. doi: 10.1017/S1478951508000254.
- Sunilkumar MM, Lockman K. Practical pharmacology of methadone: a long-acting opioid. Indian J Palliat Care. 2018;24(5):S10–S4. doi: 10.4103/IJPC.IJPC_180_17.
- Pollock AB, Tegeler ML, Morgan MD, Baumrucker SJ. Morphine to methadone conversion: an interpretation of published data. Am J Hosp Palliat Care. 2011;28(2):135–40. doi: 10.1177/1049909110373508.
- Salpeter SR, Buckley JS, Bruera E. The use of very-low-dose methadone for palliative pain control and the prevention of opioid hyperalgesia. J Palliat Med. 2013;16(6):616–22. doi: 10.1089/jpm.2012.0612.
- Mercadante S, Casuccio A, Fulfaro F, Groff L, Boffi R, Villari P, Gebbia V, Ripamonti C. Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective study. J Clin Oncol. 2001;19(11):2898–904. doi: 10.1200/JCO.2001.19.11.2898.
- Walker PW, Palla S, Pei BL, Kaur G, Zhang K, Hanohano J, Munsell M, Bruera E. Switching from methadone to a different opioid: what is the equianalgesic dose ratio? J Palliat Med. 2008;11(8):1103–8. doi: 10.1089/jpm.2007.0285.
- Ayonrinde OT, Bridge DT. The rediscovery of methadone for cancer pain management. Med J Aust. 2000;173(10):536–40.
- Plonk W. Simplified methadone conversion. J Palliat Med. 2005;8(3):478–9.
- Baumrucker SJ, Jbara M, Rogers RM. A new mathematical approach to methadone conversion. J Pharmacol Pharmacother. 2016;7(2):93–95. doi: 10.4103/0976-500X.184773.
- Vu Bach T, Pan J, Kirstein A, Grief CJ, Grossman D. Use of methadone as an adjuvant medication to low-dose opioids for neuropathic pain in the frail elderly: a case series. J Palliat Med. 2016;19(12):1351–5. doi: 10.1089/jpm.2016.0246.